InsidersTradesSigma
Track the SVAS BIOSANA stock price and the full directors' dealings record of the company, a listed issuer based in Italy. Shares trade on the IT market, under the authority of Consob. Operating in the Health Care sector, SVAS BIOSANA has published 4 insider filings. Market capitalisation: €46.5m. The latest transaction was reported on 15 April 2025 (Other). All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
SVAS BIOSANA is a company specialized in the healthcare and pharmaceutical sector. It is listed on the XMIL market.